HYDERABAD: Indian Immunologicals Ltd (IIL), market leader in animal and human vaccines, has on Tuesday announced its entry into the Aquaculture Health Segment with the launch of its products to serve the growing need in farmed shrimp and fish in the country. IIL’s foray into the segment will be in phased manner with multiple products including vaccines.
The Hyderabad-headquartered company is one of the largest producers of vaccines in Asia, producing a variety of vaccines for multiple species such as humans, cattle, sheep and goats, pigs, and other domestic animals.
IIL as a one health company, through its foray into aquaculture health segment intends to play a role in minimizing use of antibiotics, ultimately protecting our environment and health.
Though India holds the second position in the world for freshwater fish farmed production, freshwater fish farming in India is still based on traditional methods that often lead to conditions that promote diseases. Many fish farmers are tempted to use high dose of antibiotics to treat such diseases, which ultimately leads to antimicrobial resistance (AMR).
On the other hand, the hugely successful farmed shrimp industry in Indian is expected to grow by 11% against a global growth rate of 5.6%. India has established itself as the second largest farmed-shrimp producer in the world with a global market share of 14% in shrimp business. India’s annual shrimp production is around 600,000 metric ton that aggregates to more than $3 Billion with a CAGR of 32% since 2010.
Speaking at the launch function held at Hyderabad, Managing Director of IIL, Dr K Anand Kumar, “IIL is committed to introducing products including vaccines that will significantly reduce the usage of antibiotics in the aqua health industry”.
Dr. Priyabrata Pattnaik, Deputy Managing Director of IIL added “IIL with its strong R&D team has all the technological capabilities to manufacture vaccines for aqua health management”.